Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for the Treatment of BCR::ABL1-negative Acute Lymphoblastic Leukemia in Adults up to 65 Years

NCT07443592 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT07443592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07443592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for the Treatment of BCR::ABL1-negative Acute Lymphoblastic Leukemia in Adults up to 65 Years
Lead sponsor
PETHEMA Foundation
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 6, 2026
Completion date
June 1, 2033
Enrollment
330 (estimated)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia